A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Clinical trial NCT03905330 · COMPLETED
Trial details
- NCT number
- NCT03905330
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-09
- Primary completion
- 2022-09-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.